Imojev Powder for Suspension for Injection (SC)

Country: Filippini

Lingwa: Ingliż

Sors: FDA (Food And Drug Administration)

Ingredjent attiv:

Japanese Encephalitis Virus (Live, Attenuated)

Disponibbli minn:

N/A; Importer: Zuellig Pharma Corporation; Distributor: Zuellig Pharma Corporation

INN (Isem Internazzjonali):

Japanese Encephalitis Virus (Live, Attenuated)

Dożaġġ:

Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus.

Għamla farmaċewtika:

Powder for Suspension for Injection (SC)

Unitajiet fil-pakkett:

Packaging: Multi-dose vial (four doses). One box contains Type I glass vial with VVM (powder), 2 mL Type I glass vial (0.9% Sterile Sodium Solution as diluent), each equipped with halobutyl stopper and flip-off cap. (Box of 10's)., Packaging: Multi-dose vial (four doses). One box contains Type I glass vial with VVM (powder), 2 mL Type I glass vial (0.9% Ster

Manifatturat minn:

Government Pharmaceutical Organization - Merieux Biological Products Co., Ltd., Thailand

Sommarju tal-prodott:

Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus.

Data ta 'l-awtorizzazzjoni:

2022-07-13